Stockholm, October 12, 2017 — Nasdaq (Nasdaq: NDAQ) announced that BioArctic AB (short name: BIOA B), a mid cap company within the health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. BioArctic is the 88th company to list at Nasdaq’s Nordic markets* in 2017.
Founded in 2003, BioArctic is a Swedish biopharma company specialized in developing treatments that address the causes of diseases that affect the Central Nervous System. The company develops biological drugs with the potential to improve the quality of life for patients with neurodegenerative diseases like Alzheimer’s disease and Parkinson’s disease, and for patients with complete spinal cord injury. BioArctic’s laboratories and headquarters are located in Stockholm, Sweden, where approximately 45 employees and consultants are working. For more information, please visit www.bioarctic.com.
“We are very proud and pleased by the significant interest shown in BioArctic in Sweden as well as abroad during the listing process,” said Gunilla Osswald, CEO at BioArctic. “The listing will enable us to continue the development of innovative pharmaceuticals with the aim to improve the quality of life for the patients. It is with great pleasure that we welcome new and old shareholders to take part in the journey to develop BioArctic in a public environment.”
“We welcome BioArctic to the Nasdaq Stockholm main market, where it joins our growing health care sector,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “BioArctic operates in an exciting field and we look forward to stand by them on their journey as a public company.”
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact|
|+46 73 449 78 07|